Alkermes Plc

NASDAQ:ALKS USA Drug Manufacturers - Specialty & Generic
Market Cap
$4.61 Billion
Market Cap Rank
#3106 Global
#2088 in USA
Share Price
$27.65
Change (1 day)
-1.25%
52-Week Range
$26.13 - $34.96
All Time High
$80.14
About

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and … Read more

Alkermes Plc (ALKS) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: 0.093x

Based on the latest financial reports, Alkermes Plc (ALKS) has a cash flow conversion efficiency ratio of 0.093x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($170.07 Million) by net assets ($1.82 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Alkermes Plc - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how Alkermes Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Alkermes Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alkermes Plc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Alkermes Plc (1991–2025)

The table below shows the annual cash flow conversion efficiency of Alkermes Plc from 1991 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $1.82 Billion $520.75 Million 0.286x -4.51%
2024-12-31 $1.46 Billion $439.12 Million 0.300x -10.18%
2023-12-31 $1.20 Billion $401.35 Million 0.334x +1555.17%
2022-12-31 $1.04 Billion $21.04 Million 0.020x -77.95%
2021-12-31 $1.11 Billion $101.72 Million 0.091x +17.75%
2020-12-31 $1.07 Billion $82.84 Million 0.078x +16.92%
2019-12-31 $1.09 Billion $72.08 Million 0.066x -21.66%
2018-12-31 $1.17 Billion $99.28 Million 0.085x +431.28%
2017-12-31 $1.20 Billion $19.19 Million 0.016x +130.24%
2016-12-31 $1.21 Billion $-63.80 Million -0.053x -71.78%
2015-12-31 $1.31 Billion $-40.36 Million -0.031x -485.09%
2014-12-31 $1.40 Billion $11.14 Million 0.008x -90.79%
2013-12-31 $1.07 Billion $92.20 Million 0.087x -34.86%
2012-12-31 $952.37 Million $126.55 Million 0.133x +4671.29%
2011-12-31 $853.85 Million $-2.48 Million -0.003x +80.71%
2010-12-31 $392.02 Million $-5.91 Million -0.015x +49.24%
2009-12-31 $412.62 Million $-12.25 Million -0.030x -135.97%
2008-12-31 $419.23 Million $34.59 Million 0.083x -40.62%
2007-12-31 $305.31 Million $42.42 Million 0.139x -36.16%
2006-12-31 $384.65 Million $83.73 Million 0.218x -64.09%
2005-12-31 $192.24 Million $116.53 Million 0.606x +103.36%
2004-12-31 $4.11 Million $-74.25 Million -18.058x -246.28%
2003-12-31 $18.84 Million $-98.25 Million -5.215x -957.19%
2002-12-31 $98.82 Million $-48.75 Million -0.493x +32.56%
2001-12-31 $58.35 Million $-42.68 Million -0.731x -392.56%
2000-12-31 $121.14 Million $-17.99 Million -0.148x +27.45%
1999-12-31 $161.37 Million $-33.03 Million -0.205x -133.92%
1998-12-31 $162.85 Million $-14.25 Million -0.088x -1183.18%
1997-12-31 $166.69 Million $-1.14 Million -0.007x +96.86%
1996-12-31 $79.15 Million $-17.18 Million -0.217x -32.13%
1995-12-31 $33.49 Million $-5.50 Million -0.164x +61.74%
1994-12-31 $21.20 Million $-9.10 Million -0.429x -11.32%
1993-12-31 $31.90 Million $-12.30 Million -0.386x -206.54%
1992-12-31 $47.70 Million $-6.00 Million -0.126x +84.92%
1991-12-31 $54.20 Million $-45.20 Million -0.834x --